Press Releases
GNS Healthcare Taps Technology Leader as CTO to Drive Productization of Causal AI Platform
CAMBRIDGE, Mass.– August 22, 2018 – GNS Healthcare (GNS), a leading precision medicine company, announced the hiring of veteran software executive Scott McKay as Chief Technology Officer. McKay brings over 25 years of hands-on experience in software development,...
read moreThe ALS Association Partners with GNS Healthcare to Apply AI to Accelerate Answer ALS Research
GNS Healthcare to combine its powerful, causal machine learning technology with the comprehensive Answer ALS patient datasets
read moreSomaLogic Licenses GNS Healthcare’s REFS™ technology for analysis of its SOMAscan®- derived proteomic data
Combining the world-leading proteomic and artificial intelligence/machine learning technologies to produce novel, actionable health insights across many diseases, conditions and markets
read moreGNS Healthcare and Alliance for Clinical Trials in Oncology Present Results of Causal Modeling that Identifies Clinical and Molecular Drivers of Survival in Colorectal Cancer Patients
Results presented at ASCO 2018 Annual Meeting in Chicago show drivers at baseline allow better risk stratification at initiation of treatment
read moreGNS Healthcare Names Ted Goldstein, Silicon Valley Tech Innovator and Scientific Program Director of Computational Health at UCSF to its Strategic Advisory Board
CAMBRIDGE, Mass.–May 31, 2018 – GNS Healthcare (GNS), a leading precision medicine company, announced the appointment of Dr. Ted Goldstein, Scientific Program Director of Computational Health of University of California, San Francisco, to its Strategic Advisory Board...
read moreGNS Healthcare to Present Results on Prediction of Disease Progression Using AI in NASH Patients at The International Liver Congress™
CAMBRIDGE, Mass.– April 13, 2018– GNS Healthcare (GNS), a leading precision medicine company, will present results from a recent study on Friday, April 13th at the International Liver Congress™ 2018 in Paris. The analysis focused on the progression of Nonalcoholic...
read moreGNS Healthcare Names Patrick Getzen, Chief Data and Analytics Officer of Blue Cross and Blue Shield of North Carolina, to its Strategic Advisory Board
CAMBRIDGE, Mass.– February 6, 2018 – GNS Healthcare (GNS), a leading precision medicine company, announced the appointment of Patrick Getzen, Chief Data and Analytics Officer of Blue Cross and Blue Shield of North Carolina (Blue Cross NC), to its Strategic Advisory...
read moreGNS Healthcare Uses Causal AI to Discover Which Multiple Myeloma Patients Will Have Progression Free Survival Benefit from Stem Cell Treatments
Details of the Discovery Leveraging the Multiple Myeloma Research Foundation CoMMpass Study Presented at 59th Annual ASH Meeting
read moreGNS Healthcare Names Dr. David Sontag to its Strategic Advisory Board
CAMBRIDGE, Mass. – November 8, 2017– Leading precision medicine company GNS Healthcare (GNS) today announced the appointment of Dr. David Sontag to its Strategic Advisory Board (SAB). Dr. Sontag's research interests include machine learning and artificial intelligence...
read moreAI-Driven Discovery of Novel Predictors of Parkinson’s Disease Progression by GNS Healthcare Appears in The Lancet Neurology
Discovery May Accelerate the Development of New Drugs and Better Match New Drugs to Individual Patients
read more